Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05679895
Title Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL (CARxALL)
Acronym CARxALL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OneChain Immunotherapeutics
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries ESP


No variant requirements are available.